No FDA Approval For CTIC, Yet - FDA Panel Rejects Cell Therapeutics Pixantrone

Shares of Cell Therapeutics Inc (CTIC) have been halted this morning as the FDA Advistory Panel has now come out and rejected their lymphoma drug Pixantrone. When CTIC does reopen, I'd expect the stock to be cut in half atleast. CTIC still has a slight chance of approval when the FDA decision takse place at the end of April. Usually, the FDA will follow their panel ( today's vote ) but not always. With such a huge overwhelming vote, the FDA will likely to reject Pixantrone in April. Cell Therapeutics will probably need to raise more capital if it plans to continue Pixantrone.

US panel rejects Cell Therapeutics lymphoma drug


Today's Biggest Stock Market Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Stocks for 2010

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free